Radiosensitisation of Squamous Cell Carcinoma of the Penis in Men Who Are Positive for Human Papillomavirus Infection.
Raison N, Minhas S.
Eur Urol Oncol. 2021 Oct;4(5):811-812. doi: 10.1016/j.euo.2020.12.005. Epub 2020 Dec 23.
Squamous cell carcinoma of the penis.
Micali G, Innocenzi D, Nasca MR, Musumeci ML, Ferraú F, Greco M.
J Am Acad Dermatol. 1996 Sep;35(3 Pt 1):432-51. doi: 10.1016/s0190-9622(96)90611-8.
Etiology of squamous cell carcinoma of the penis.
Dillner J, von Krogh G, Horenblas S, Meijer CJ.
Scand J Urol Nephrol Suppl. 2000;(205):189-93. doi: 10.1080/00365590050509913.
Management of advanced squamous cell carcinoma of the penis.
Connell CF, Berger NA.
Urol Clin North Am. 1994 Nov;21(4):745-56.
[A Case of Sarcomatoid Squamous Cell Carcinoma of the Penis].
Wanifuchi A, Shimizu T, Hotta H.
Hinyokika Kiyo. 2018 Feb;64(2):79-82. doi: 10.14989/ActaUrolJap_64_2_79.
Squamous cell carcinoma of the penis.
Schoeneich G, Perabo FG, Müller SC.
Andrologia. 1999;31 Suppl 1:17-20. doi: 10.1111/j.1439-0272.1999.tb01445.x.
Atezolizumab in Advanced Squamous Cell Carcinoma of the Penis.
Feng YN, Xiao L, Xie GY.
J Clin Oncol. 2024 Jan 10;42(2):242-243. doi: 10.1200/JCO.23.01818. Epub 2023 Nov 16.
Squamous cell carcinoma of the penis.
Hoppmann HJ, Fraley EE.
J Urol. 1978 Oct;120(4):393-8. doi: 10.1016/s0022-5347(17)57197-9.
Prognostic Value of the Neutrophil/Lymphocyte Ratio in Squamous Cell Carcinoma of the Penis.
Díaz de Mera-Sánchez Migallón I, Carrión-López P, Jesús Fernández-Anguita P, Herraiz-Raya L, Legido-Gómez Ó, Salinas-Sánchez AS.
Arch Esp Urol. 2022 Oct;75(8):706-713. doi: 10.56434/j.arch.esp.urol.20227508.102.
Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis.
Trimmel B, Oszwald A, Diemand C, Ertl IE, Lemberger U, Bruchbacher A, Brettner R, Korn S, Resch I, Comperat E, Shariat SF, Hassler MR.
Sci Rep. 2022 Jul 28;12(1):12911. doi: 10.1038/s41598-022-17056-8.
